The US National Institutes of Health (NIH) and the Patenting and Trademark Office (USPTO) are in disagreement over the patenting of genes with no known function, according to a news report in last week's Nature. USPTO officials say that patents can be granted on genes with no known function if...
The key to understanding the human genome will be sequencing the genome of the lab mouse, according to scientists attending the recent human genome meeting in Vancouver. 'That will be the Rosetta Stone in terms of interpreting the human genome', said Steven Jones of the Genome Sequence Centre in Vancouver...
Many European biotech companies are running out of cash, according to a recent report by accountancy firm Ernst and Young. The study found that the sector leapt in value by 66 per cent to £11bn in 1999, following two years of decline. But a 'survival index' in the report showed...
The announcement by biotech company Celera Genomics that it has 'finished' sequencing the human genome has been disputed by scientists from the publicly-funded Human Genome Project. They have questioned the Celera's claims that it will assemble the complete sequence within six weeks. Speaking at the Human Genome Mapping 2000 meeting...
US firm Celera Genomics claimed last week that it has finished sequencing 99 per cent of the human genome, and is now putting the information together in a meaningful order. The announcement follows a statement last week from the publicly-funded Human Genome Project, which aims to publish a rough draft...
US president Bill Clinton and UK prime minister Tony Blair have issued a joint statement urging all human genome researchers to place their results in the public domain. 'Raw fundamental data on the human genome, including the human DNA sequence and its variations, should be made freely available to scientists...
Scientists have nearly finished sequencing the fruit fly genome, almost a year ahead of schedule. American firm Celera Genomics, along with the Berkley Drosophila Genome Project and The European Drosophila Project, will publish their joint results in the journal Science next month. The announcement boosts Celera's controversial claim that it...
This week's announcement by Celera Genomics that it has DNA sequences totalling more than 90 percent of the genome in its database has certainly increased the value of Celera on the stock market. However, it has also brought the public/private genomics debate back to life. Celera officials openly admit...
An international team of researchers has passed a scientific milestone by deciphering, for the first time, the complete genetic code of a human chromosome. Reporting in last week's Nature, researchers from the Wellcome Trust funded Sanger Centre in Cambridge, Keio University in Japan and various US laboratories announced their success...
The Wellcome Trust is to fund a £10m Cancer Genome Project to detect genes that are mutated in human cancers and release that information to a public database. The project will be based at the Sanger Centre near Cambridge which forms a part of the international Human Genome Project - a...
Stay up-to-date on all the latest developments in the fields of human fertility and genomics. And be the first to hear about upcoming events and other announcements.
